Presentation
3 May 2016 Preanalytical considerations in detection of colorectal cancer in blood serum using Raman molecular imaging (Conference Presentation)
Patrick J. Treado, Shona D. Stewart, Aaron Smith, Heather Kirschner, Christopher Post, Bergein F. Overholt M.D.
Author Affiliations +
Abstract
Colorectal cancer (CRC) is the third most common cancer in men and women in the United States. Raman Molecular Imaging (RMI) is an effective technique to evaluate human tissue, cells and bodily fluids, including blood serum for disease diagnosis. ChemImage Corporation, in collaboration with clinicians, has been engaged in development of an in vitro diagnostic Raman assay focused on CRC detection. The Raman Assay for Colorectal Cancer (RACC) exploits the high specificity of Raman imaging to distinguish diseased from normal dried blood serum droplets without additional reagents. Pilot Study results from testing of hundreds of biobank patient samples have demonstrated that RACC detects CRC with high sensitivity and specificity. However, expanded clinical trials, which are ongoing, are revealing a host of important preanalytical considerations associated with sample collection, sample storage and stability, sample shipping, sample preparation and sample interferents, which impact detection performance. Results from recent clinical studies will be presented.
Conference Presentation
© (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Patrick J. Treado, Shona D. Stewart, Aaron Smith, Heather Kirschner, Christopher Post, and Bergein F. Overholt M.D. "Preanalytical considerations in detection of colorectal cancer in blood serum using Raman molecular imaging (Conference Presentation)", Proc. SPIE 9704, Biomedical Vibrational Spectroscopy 2016: Advances in Research and Industry, 970409 (3 May 2016); https://doi.org/10.1117/12.2212776
Advertisement
Advertisement
KEYWORDS
Raman spectroscopy

Colorectal cancer

Blood

Error control coding

Molecular imaging

Cancer

Clinical trials

Back to Top